Toronto, Ontario–(Newsfile Corp. – March 2, 2021) – Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the “Company” or “Psyched“), a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce the company has received the results from its Maximum Tolerated Dosage (MTD) study conducted by KGK Science…


Previous articlePsychedelics Company Silo Wellness Inc. (Formerly Yukoterre Resources Inc.) Announces Successful Completion of Reverse Take-Over Transaction
Next articleNuminus and Syreon Provide Psilocybin Compassionate Access Trial Update